a decreasing trendP < 0.001
The average age showed a decreasing trend from T1 to T3 (68.25 ± 8.21, 63.51 ± 8.65, and 60.74 ± 8.90 years, respectively; P < 0.001).
The average age showed a decreasing trend from T1 to T3 (68.25 ± 8.21, 63.51 ± 8.65, and 60.74 ± 8.90 years, respectively; P < 0.001).
Notably, we observed a borderline significant effect modification by sex (interaction P = 0.051), with women showing a stronger inverse association (OR = 0.98, 95% CI: 0.96–0.99), while no significant association was found in men (OR = 1.00, 95% CI: 0.99–1.02).
Additionally, although the interaction did not reach statistical significance (interaction P = 0.105), the inverse association between eGFR and LCAS was more pronounced in statin users (OR = 0.97, 95% CI: 0.95–0.99) compared to non-users (OR = 0.99, 95% CI: 0.98–1.01).